These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3673627)

  • 1. [Biopharmaceutical evaluation of the rectal administration of mefenamic acid. IV. Biological availability of mefenamic acid on the base of polyoxyethylene glycol with the addition of polysorbates].
    Kosior A
    Acta Pol Pharm; 1987; 44(1):91-5. PubMed ID: 3673627
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biopharmaceutical evaluation of the rectal application of mefenamic acid. I. Study of the suppositories prepared on hydrophilic bases].
    Kosiar A
    Acta Pol Pharm; 1983; 40(1):105-9. PubMed ID: 6880815
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biopharmaceutical evaluation of the rectal administration of mefenamic acid. II. Analysis of suppositories prepared on lipophilic bases].
    Kosior A
    Acta Pol Pharm; 1984; 41(5):565-9. PubMed ID: 6532137
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biopharmaceutical evaluation of the intrarectal use of mefenamic acid. III. Effect of solubilizers on the biological availability of mefenamic acid from witepsol H15].
    Kosior A
    Acta Pol Pharm; 1986; 43(2):156-60. PubMed ID: 3776655
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of dissolution and absorption of mefenamic acid by egg albumin.
    Imai T; Nohdomi K; Acartürk F; Otagiri M
    J Pharm Sci; 1991 May; 80(5):484-7. PubMed ID: 1880730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bioavailability and pharmacokinetics of mefenamic acid in alloxan-diabetic rabbits.
    Qamar S; Irfan N; Ahmad M; Jamshaid M; Muzaffar NA
    Tokai J Exp Clin Med; 1997 Oct; 22(4):163-6. PubMed ID: 9777006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biopharmaceutical evaluation of the effect of an ointment base composition on the biological availability of hydrocortisone acetate in the ointment].
    Umer S
    Acta Pol Pharm; 1985; 42(2):172-6. PubMed ID: 4083054
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of encapsulation of mefenamic acid with cationic Eudragit E on its bioavailability and gastric ulcerogenic activity in rabbits.
    Ramadan EM; el-Helw A; el-Said Y
    J Microencapsul; 1987; 4(2):125-32. PubMed ID: 3504500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of fast-release mephenamic acid microspheres.
    Etman M; Farid R; Nada A; Ebian A
    J Microencapsul; 2010; 27(7):640-56. PubMed ID: 20681746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the permeation enhancement of mefenamic acid by ethanol across full-thickness skin, heat-separated epidermal membrane and heat-separated dermal membrane.
    Heard CM; Screen C
    Int J Pharm; 2008 Feb; 349(1-2):323-5. PubMed ID: 17870262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Optimization of the technology and a biopharmaceutic study of mefenamic acid suppositories].
    Golovkin VA; Lukash EP; Fadeicheva AG; Groshovyĭ TA; Mokhort NA
    Farmatsiia; 1978; 27(4):16-9. PubMed ID: 689174
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative bioavailability of two capsule formulations of mefenamic acid.
    Rawashdeh NM; Najib NM; Jalal IM
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):329-33. PubMed ID: 9266288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of dressings developed for the treatment of alveolitis sicca dolorosa. Part 2: Influence of glycerol and PEG 200 on the properties of tablets and dressings comprising mefenamic acid and Nipagin P.
    Grabowska-Bochenek J; Kubis A
    Pharmazie; 1986 Sep; 41(9):648-50. PubMed ID: 3797456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Layered double hydroxide nanocarriers: potential delivery systems for mefenamic acid.
    Prasher P; Sharma M
    Nanomedicine (Lond); 2023 Oct; 18(24):1697-1701. PubMed ID: 37877695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glyceride derivatives as potential prodrugs: synthesis, biological activity and kinetic studies of glyceride derivatives of mefenamic acid.
    Khan MS; Akhter M
    Pharmazie; 2005 Feb; 60(2):110-4. PubMed ID: 15739898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of charcoal on mefenamic acid elimination.
    Allen EM; Buss DC; Williams J; Routledge PA
    Br J Clin Pharmacol; 1987 Dec; 24(6):830-2. PubMed ID: 3440104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mefenamic acid bioequivalence assessment with a new statistical procedure.
    Rescigno A; Marzo A; Thyroff-Friesinger U
    Pharmacol Res; 1996; 34(3-4):149-52. PubMed ID: 9051707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative dissolution studies for mefenamic acid-polyethylene glycol solid dispersion systems and tablets.
    Owusu-Ababio G; Ebube NK; Reams R; Habib M
    Pharm Dev Technol; 1998 Aug; 3(3):405-12. PubMed ID: 9742561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmaceutical evaluation of a hollow type suppository. III. Effect of macrogol 300 on the bioavailability of indomethacin in rabbits].
    Watanabe Y; Tone Y; Suzuki M; Matsumoto M
    Yakugaku Zasshi; 1985 Mar; 105(3):284-8. PubMed ID: 4032233
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biopharmaceutical characteristics of sodium mefenaminate suppositories].
    Slobodianiuk MM
    Farm Zh; 1978; (3):88-9. PubMed ID: 680117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.